These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7308095)

  • 1. N-acetylation phenotype profile in healthy African volunteers using sulphadimidine.
    Adam AM; Ng'anga J; Muthaura C
    East Afr Med J; 1981 Jun; 58(6):401-4. PubMed ID: 7308095
    [No Abstract]   [Full Text] [Related]  

  • 2. Pantothenic acid, acute ethanol consumption and sulphadimidine acetylation.
    Vas A; Gachályi B; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1990 Mar; 28(3):111-4. PubMed ID: 2318546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylation phenotype and skin complexion.
    Rampen FH; van der Meeren HL; Stolk LM
    Acta Derm Venereol; 1986; 66(4):334-6. PubMed ID: 2430405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of exercise on plasma levels and urinary excretion of sulphadimidine and procainamide.
    Ylitalo P; Hinkka H
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):548-53. PubMed ID: 4066079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of concomitant isoniazid administration on determination of acetylator phenotype by sulphadimidine.
    Zysset T; Peretti E
    Eur J Clin Pharmacol; 1986; 30(4):463-6. PubMed ID: 3743623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of sulphadimidine acetylation test in urine and blood for isoniazid phenotyping.
    Nair CR; Gupta RC; Varshneya AK; Malik SK
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):646-7. PubMed ID: 6526538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intersubject variability of sulphadimidine acetylation in student volunteers [proceedings].
    Liscombe DK; Nicholls PJ
    Br J Pharmacol; 1976 Oct; 58(2):312P-313P. PubMed ID: 974428
    [No Abstract]   [Full Text] [Related]  

  • 8. N-Acetylation phenotyping with sulfamethazine--problems of sampling.
    Siegmund W; Franke G; Kibittel F; Krüger R
    Pharmazie; 1989 Oct; 44(10):729-30. PubMed ID: 2616620
    [No Abstract]   [Full Text] [Related]  

  • 9. N-acetylation phenotyping with sulfamethazine in an Iranian population.
    Sardaş S; Lahijany B; Cok I; Karakaya AE
    Pharmacogenetics; 1993 Jun; 3(3):131-4. PubMed ID: 8334437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phenotypes of oxidation and acetylation in Alzheimer's disease--preliminary report].
    Milejski P; Orzechowska-Juzwenko K; Niewiński P; Hurkacz M; Czarnik-Matusewicz H; Leszek J; Rudzik J; Grotthus B
    Psychiatr Pol; 2007; 41(2):261-9. PubMed ID: 17598435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acetylation of sulphadimidine in some liver diseases].
    Kaláb M; Perlík F; Kordac V
    Cas Lek Cesk; 1982 Aug; 121(32):1001-3. PubMed ID: 7127378
    [No Abstract]   [Full Text] [Related]  

  • 12. Sulphadimidine acetylation status in Gujarati and Marathi population.
    Kshirsagar NA; Pohujani SM; Takle MR; Acharya VN; Satoskar RS
    J Postgrad Med; 1987 Jul; 33(3):128-33. PubMed ID: 3430399
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnosis of acetylation phenotype in the protection of production personnel].
    Evgen'ev MI; Garmonov SIu; Bagniuk VP; Maksudova SE; Kochergin AV
    Med Tr Prom Ekol; 2002; (11):35-8. PubMed ID: 12520909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of physical training on sulfamethazine acetylation rate.
    Abzalov RA; Nigmatullina RR; Khairullina GN; Garmonov SY; Shakirova LS; Evgen'ev MI
    Bull Exp Biol Med; 2000 Dec; 130(12):1141-3. PubMed ID: 11276304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability factors of isoniazid in fast and slow acetylators, healthy volunteers.
    Augustynowicz-Kopeć E; Zwolska Z
    Acta Pol Pharm; 2002; 59(6):452-7. PubMed ID: 12669770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The determination of the acetylator phenotype of tuberculosis patients in Czechoslovakia using sulphadimidine.
    Víznerová A; Slavíková Z; Ellard GA
    Tubercle; 1973 Mar; 54(1):67-71. PubMed ID: 4774936
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of phenazone oxidation and sulfadimidine acetylation in patients with hematologic neoplasms].
    Wiela-Hojeńska A; Milejski P; Orzechowska-Juzwenko K; Usnarska-Zubkiewicz L; Urbaniak-Kujda D; Kotlarek-Haus S
    Przegl Lek; 1997; 54(3):163-6. PubMed ID: 9297191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulphadimidine acetylation test for classification of patients as slow or rapid inactivators of isoniazid.
    Rao KV; Mitchison DA; Nair NG; Prema K; Tripathy SP
    Br Med J; 1970 Aug; 3(5721):495-7. PubMed ID: 5454342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic polymorphism in Gilbert-Meulengracht syndrome (GMS)].
    Fengler JD; Baumgarten R; Eike E; Eike O; Siegmund W; Franke G; Zschiesche M
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():81-2. PubMed ID: 7483725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis.
    Singh SP; Pande JN; Khilnani GC; Kailash S
    Indian J Chest Dis Allied Sci; 1996; 38(1):5-11. PubMed ID: 16892742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.